Ulrika Nillroth
Roche (Sweden)(SE)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, HIV Research and Treatment, Carbohydrate Chemistry and Synthesis, Chemical Synthesis and Analysis, Click Chemistry and Applications
Most-Cited Works
- → Cyclic HIV-1 Protease Inhibitors Derived from Mannitol: Synthesis, Inhibitory Potencies, and Computational Predictions of Binding Affinities(1997)161 cited
- → Design and Synthesis of New PotentC2-Symmetric HIV-1 Protease Inhibitors. Use ofl-Mannaric Acid as a Peptidomimetic Scaffold(1998)77 cited
- → HIV-1 Protease Inhibitors Based on Acyclic Carbohydrates(1998)44 cited
- → Synthesis of enantiomerically pure cis and trans 2-aminocyclopentanecarboxylic acids. Use of proline replacements in potential HIV-protease inhibitors(1997)29 cited
- → Cerebrospinal fluid HIV-1 RNA, intrathecal immunoactivation, and drug concentrations after treatment with a combination of saquinavir, nelfinavir, and two nucleoside analogues: the M61022 study(2006)26 cited
- → A convenient synthesis of 1-(S)-[1′-(S)-(t-butyloxycarbonylamino)-2′-phenylethyl]oxirane. A useful building block in the synthesis of HIV protease inhibitors(1997)24 cited
- → Investigation of an Allosteric Site of HIV-1 Proteinase Involved in Inhibition by Cu2+(1998)19 cited
- → Synthesis ofC2Symmetric Potential Inhibitors of HIV-1 Protease From D-Mannitol(1996)6 cited
- Inhibition of HIV-1 protease by Cu2+ occurs by a reversible allosteric mechanism involving His-69(2004)
- Cyclic urea and sulfamide-based inhibitors of HIV-1 protease: Changes in binding mode upon modifications in the P1/P1 side chain(1998)